<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32925088</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2214-3602</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Journal of neuromuscular diseases</Title><ISOAbbreviation>J Neuromuscul Dis</ISOAbbreviation></Journal><ArticleTitle>The Canadian Neuromuscular Disease Registry 2010-2019: A Decade of Facilitating Clinical Research Througha Nationwide, Pan-NeuromuscularDisease Registry.</ArticleTitle><Pagination><StartPage>53</StartPage><EndPage>61</EndPage><MedlinePgn>53-61</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/JND-200538</ELocationID><Abstract><AbstractText>We report the recruitment activities and outcomes of a multi-disease neuromuscular patient registry in Canada. The Canadian Neuromuscular Disease Registry (CNDR) registers individuals across Canada with a confirmed diagnosis of a neuromuscular disease. Diagnosis and contact information are collected across all diseases and detailed prospective data is collected for 5 specific diseases: Amyotrophic Lateral Sclerosis (ALS), Duchenne Muscular Dystrophy (DMD), Myotonic Dystrophy (DM), Limb Girdle Muscular Dystrophy (LGMD), and Spinal Muscular Atrophy (SMA). Since 2010, the CNDR has registered 4306 patients (1154 pediatric and 3148 adult) with 91 different neuromuscular diagnoses and has facilitated 125 projects (73 academic, 3 not-for-profit, 3 government, and 46 commercial) using registry data. In conclusion, the CNDR is an effective and productive pan-neuromuscular registry that has successfully facilitated a substantial number of studies over the past 10 years.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hodgkinson</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Clinical Neurosciences, and Hotchkiss Brain Institute, University of Calgary, Calgary, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lounsberry</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Neurosciences, and Hotchkiss Brain Institute, University of Calgary, Calgary, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M'Dahoma</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical Neurosciences, and Hotchkiss Brain Institute, University of Calgary, Calgary, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Russell</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical Neurosciences, and Hotchkiss Brain Institute, University of Calgary, Calgary, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jewett</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Clinical Neurosciences, and Hotchkiss Brain Institute, University of Calgary, Calgary, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benstead</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Neurology, Dalhousie University, Halifax, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brais</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Montreal Neurological Institute and Hospital, Montreal, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campbell</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Children's Health Research Institute, London Health Sciences Centre, Western University, London, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnston</LastName><ForeName>W</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, Faculty of Medicine, University of Alberta, Edmonton, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lochm&#xfc;ller</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, The Ottawa Hospital and Brain and Mind Research Institute, University of Ottawa, Ottawa, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCormick</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>C T</ForeName><Initials>CT</Initials><AffiliationInfo><Affiliation>CHU Sainte-Justine, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Ferrall</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Montreal Neurological Institute and Hospital, Montreal, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosciences, McGill University, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oskoui</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, McGill University, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Pediatrics, Montreal Children's Hospital, McGill University, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abrahao</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briemberg</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>GF Strong Rehabilitation Centre, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, Vancouver General Hospital, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bourque</LastName><ForeName>P R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Division of Physical Medicine and Rehabilitation, Department of Medicine, University of Ottawa, Ottawa, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Botez</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (CHUM), Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cashman</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>GF Strong Rehabilitation Centre, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, Vancouver General Hospital, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chapman</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, Vancouver General Hospital, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chrestian</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine, Universit&#xe9; Laval, Quebec City, Canada, Neuroscience axis, CHU de Qu&#xe9;bec-Universit&#xe9; Laval.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crone</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Pediatric Neurology, Department of Neurology, University of Saskatchewan, Saskatoon, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dobrowolski</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, Faculty of Medicine, University of Alberta, Edmonton, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dojeiji</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Physical Medicine and Rehabilitation, Department of Medicine, University of Ottawa, Ottawa, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dowling</LastName><ForeName>J J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Sick Kids Hospital, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dupr&#xe9;</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine, Laval University, Qu&#xe9;bec City, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Genge</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, McGill University, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonorazky</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Sick Kids Hospital, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grant</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Division of Neurology, Dalhousie University, Halifax, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasal</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Pediatric Neurology, Department of Neurology, University of Saskatchewan, Saskatoon, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izenberg</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalra</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, Faculty of Medicine, University of Alberta, Edmonton, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katzberg</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University Health Network, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krieger</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>GF Strong Rehabilitation Centre, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, Vancouver General Hospital, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leung</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linassi</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation University of Saskatchewan, Saskatoon, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mackenzie</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mah</LastName><ForeName>J K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Department of Clinical Neurosciences, and Hotchkiss Brain Institute, University of Calgary, Calgary, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of Calgary, Calgary, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marrero</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CHU Dr. Georges-L-Dumont, Universit&#xe9; de Sherbrooke, Moncton, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Massie</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Montreal Neurological Institute and Hospital, Montreal, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosciences, McGill University, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matte</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al (CHUM), Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McAdam</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Holland Bloorview Kids Rehabilitation Hospital, Bloorview Research Institute, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McMillan</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, Faculty of Medicine, University of Alberta, Edmonton, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melanson</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Queen's University, Kingston, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mezei</LastName><ForeName>M M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, Vancouver General Hospital, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Connell</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Stan Cassidy Centre for Rehabilitation, Fredericton, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Dalhousie University, Halifax, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pfeffer</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Clinical Neurosciences, and Hotchkiss Brain Institute, University of Calgary, Calgary, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Genetics, and Alberta Child Health Research Institute, University of Calgary, Calgary, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phan</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, Faculty of Medicine, University of Alberta, Edmonton, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plamondon</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical Neurosciences, and Hotchkiss Brain Institute, University of Calgary, Calgary, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poulin</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Departments of Pediatrics, Montreal Children's Hospital, McGill University, Montr&#xe9;al, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodrigue</LastName><ForeName>X</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Medicine, Laval University, Qu&#xe9;bec City, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schellenberg</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation University of Saskatchewan, Saskatoon, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Selby</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Pediatrics, BC Children's Hospital, University of Vancouver, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheriko</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Pediatrics, Dalhousie University, Halifax, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shoesmith</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Neurology, Clinical Neurological Sciences, Western University, London, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>R G</ForeName><Initials>RG</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, KidsInclusive Centre for Child &amp; Youth Development, Hotel Dieu Hospital, Queen's University, Kingston, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taillon</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Stan Cassidy Centre for Rehabilitation, Fredericton, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Dalhousie University, Halifax, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Neurology, Dalhousie University, Halifax, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Venance</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Neurology, Clinical Neurological Sciences, Western University, London, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warman-Chardon</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medicine, The Ottawa Hospital and Brain and Mind Research Institute, University of Ottawa, Ottawa, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Worley</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Stan Cassidy Centre for Rehabilitation, Fredericton, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Dalhousie University, Halifax, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zinman</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korngut</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Clinical Neurosciences, and Hotchkiss Brain Institute, University of Calgary, Calgary, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Neuromuscul Dis</MedlineTA><NlmUniqueID>101649948</NlmUniqueID><ISSNLinking>2214-3599</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009134" MajorTopicYN="Y">Muscular Atrophy, Spinal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049288" MajorTopicYN="Y">Muscular Dystrophies, Limb-Girdle</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020388" MajorTopicYN="Y">Muscular Dystrophy, Duchenne</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009223" MajorTopicYN="Y">Myotonic Dystrophy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="Y">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Registry</Keyword><Keyword MajorTopicYN="N">natural history</Keyword><Keyword MajorTopicYN="N">real-world evidence</Keyword></KeywordList><CoiStatement>Dr. Hodgkinson reports personal fees from Biogen, Roche, Sarepta, outside the submitted work. Mr. Lounsberry reports personal fees from Biogen Canada Limited, outside the submitted work; Dr. M&#x2019;Dahoma has nothing to disclose. Ms. Russell has nothing to disclose. Dr. Jewett has nothing to disclose. Dr. Benstead has nothing to disclose. Dr. Campbell reports grants, personal fees and other from Biogen, grants, personal fees and other from PTC Therapeutics, other from Acceleron, AMO, Catabasis, Pfizer, Sarepta, Wave, BMS. Scholar Rock, Roche, outside the submitted work; Dr. McCormick has nothing to disclose. Dr. Johnston declares personal fees from Mitsubishi Tanabe, and clinical trials from Alexion, Cytokinetics, Biogen, Orion, Mallinkrodt, Apellis, Alexion, AB Science; Dr. Nguyen reports other from Pfizer, other from Catabasis outside the submitted work. Dr. O&#x2019;Ferrall reports personal fees from PTC Therapeutics nmDMD Advisory Board; grants from Sanofi Genzyme, grants from Acceleron, grants from Sanofi Genzyme, grants from Grifols, outside the submitted work. Dr. Oskoui reports grants from Fonds de Recherche Sante du Qu&#xe9;bec, grants from Kids Brain Health Network, grants from Canadian Institutes of Health Research, grants from SickKids Foundation, grants from Cerebral Palsy Alliance Research Foundation, other from Ionis, other from Biogen, other from Roche, other from Cytokinetics, personal fees and non-financial support from American Academy of Neurology, grants from Fondation du Grand Defi Pierre Lavoie, outside the submitted work; Dr. Brais has nothing to disclose. Dr. Briemberg has nothing to disclose. Dr. Bourque has nothing to disclose. Dr.&#xa0;Botez has nothing to disclose. Dr. Cashman reports ownership of ProMIS Neurosciences, outside the submitted work. Dr. Chapman has nothing to disclose. Dr. Chrestian received financial support to prepare review courses about SMA for neurologists, Physical therapists and Paediatricians. Dr. Crone reports personal fees from Biogen, outside the submitted work. Dr. Dobrowolski has nothing to disclose. Dr. Dojeiji has nothing to disclose. Dr. Dowling has nothing to disclose. Dr. Dupr&#xe9; has nothing to disclose. Dr. Genge reports grants from Biogen, Sanofi-Genzyme, CSL Behring, MTPA, AL-S Pharma, AB Sciences, Novartis, Wave Life Sciences, Argenx, Alexion, Avexis, Ackea, Cytokinetics, Hoffman-La Roche, outside the submitted work. Dr. Gonorazky reports personal fees from Biogen. Dr. Grant has nothing to disclose. Dr. Hasal has nothing to disclose. Dr. Izenberg has nothing to disclose. Dr. Kalra has nothing to disclose. Dr. Katzberg reports grants from CSL Behring, Takaeda and Muscular Dystrophy Canada and personal fees from Takada, Grifols, CSL Behring, Terumo, Biogen, Pfizer, Akcea, Alexion, Octapharma outside the submitted work. Dr. Krieger has nothing to disclose. Dr. Leung has nothing to disclose. Dr. Linassi has nothing to disclose. Dr. Lochm&#xfc;ller reports grants and personal fees from AMO Pharma, Biogen, Desitin, GW Pharma, Pfizer, PTC Therapeutics, Roche, Santhera, Sarepta, Satellos, Ultragenyx, outside the submitted work;. Dr. MacKenzie reports grants from Biogen, outside the submitted work. Dr. Mah has nothing to disclose. Dr. Marrero has nothing to disclose. Dr. Massie has nothing to disclose. Dr. Matte reports personal fees from Mitsubishi Tanabe, Biogen outside the submitted work, and grants from Biogen, Cytokinetics, Orion, Mallinckrodt outside the submitted work. Dr. McAdam reports other from Italfarmaco, outside the submitted work. Dr. McMillan has nothing to disclose. Dr. Melanson has nothing to disclose. Dr. Mezei reports personal fees from Genzyme, Alnylam, Pfizer, Akcea, CSL Behring, outside the submitted work. Dr. O&#x2019;Connell reports personal fees from MT Pharma, grants and personal fees from Canopy Growth, personal fees from IPSEN, grants from Cytokinetics, grants from Mallincrodtk, grants from Orion, personal fees from Shoppers Drug Mart, outside the submitted work. Dr. Pfeffer has nothing to disclose. Dr. Phan has nothing to disclose. Dr. Plamondon reports other from Biogen, outside the submitted work; Dr. Poulin has nothing to disclose. Dr. Rodrigue has nothing to disclose. Dr. Schellenberg received grants for educational activities: Genzyme, Allergan, Mitsubishi-Tanabe; speakers honoraria: Genzyme, EMD Serono, Akcea, and advisory board: Mitsubishi-Tanabe, Alexion, Roche, Biogen, Akcea. Dr. Selby reports grants from Biogen/IONIS, personal fees from Biogen, outside the submitted work. Dr. Sheriko reports personal fees from Biogen, outside the submitted work. Dr. Shoesmith reports other from Biogen, outside the submitted work. Dr. Smith reports personal fees from Shire Pharmaceuticals, personal fees from Purdue Pharmaceuticals, personal fees from Janssen Pharmaceuticals, outside the submitted work. Dr. Taillon reports grants from Allergan, personal fees from Biogen outside the submitted work. Dr. Taylor has nothing to disclose. Dr. Venance has nothing to disclose. Dr. Warman has nothing to disclose. Dr. Worley reports personal fees from Cytokinetics, outside the submitted work. Dr. Zinman reports personal fees from Mitsubishi Tanabe and Biogen outside the submitted work. Dr. Korngut reports grants from Biogen, Sanofi Genzyme, ALS Canada, Jesse&#x2019;s Journey, during the study, and personal fees from Alexion, Alnylam, Novartis, Mitsubishi Tanabe, Sarepta, Biogen, CSL Behring, outside the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>14</Day><Hour>15</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32925088</ArticleId><ArticleId IdType="pmc">PMC7902956</ArticleId><ArticleId IdType="doi">10.3233/JND-200538</ArticleId><ArticleId IdType="pii">JND200538</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Deenen JC, Horlings CG, Verschuuren JJ, Verbeek AL, van Engelen BG. The epidemiology of neuromuscular disorders: A comprehensive overview of the literature. J Neuromuscul Dis. 2015;2(1):73&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">28198707</ArticleId></ArticleIdList></Reference><Reference><Citation>Population density (people per sq. km of land area) [Internet]. Data. [cited 2020 May 12]. Available from: https://data.worldbank.org/indicator/EN.POP.DNST</Citation></Reference><Reference><Citation>World Population Prospects - Population Division [Internet]. United Nations. [cited 2020 May 12]. Available from: https://population.un.org/wpp/Download/Standard/Population/.</Citation></Reference><Reference><Citation>Korngut LM, Johnston M, Pringsheim T, Jette N. The future of neurological patient registries. Clinical Practice. 2014.</Citation></Reference><Reference><Citation>Gaskin J, Gomes J, Darshan S, Krewski D. Burden of neurological conditions in Canada. Neurotoxicology. 2017;61:2&#x2013;10. doi: 10.1016/j.neuro.2016.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2016.05.001</ArticleId><ArticleId IdType="pubmed">27153747</ArticleId></ArticleIdList></Reference><Reference><Citation>Korngut L, Campbell C, Johnston M, Benstead T, Genge A, Mackenzie A, et al. The CNDR: Collaborating to translate new therapies for Canadians. Can J Neurol Sci. 2013;40 5:698&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pubmed">23968944</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland LP, McLeod JG. Classification of neuromuscular disorders. J Neurol Sci. 1994;124 Suppl:109&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">7807135</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)&#x2013;a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377&#x2013;81. doi: 10.1016/j.jbi.2008.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2008.08.010</ArticleId><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Statistics Canada. [Internet] Table 17-10-0005-01 Population estimates on July 1st, by age and sex, 2018. [cited 2020 May 12] Available from: https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1710000501</Citation></Reference><Reference><Citation>Verhaart IEC, Robertson A, Leary R, McMacken G, Konig K, Kirschner J, et al. A multi-source approach to determine SMA incidence and research ready population. J Neurol. 2017;264(7):1465&#x2013;73. doi: 10.1007/s00415-017-8549-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-017-8549-1</ArticleId><ArticleId IdType="pmc">PMC5502065</ArticleId><ArticleId IdType="pubmed">28634652</ArticleId></ArticleIdList></Reference><Reference><Citation>Mah JK, Korngut L, Dykeman J, Day L, Pringsheim T, Jette N. A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy. Neuromuscul Disord. 2014;24(6):482&#x2013;91. doi: 10.1016/j.nmd.2014.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2014.03.008</ArticleId><ArticleId IdType="pubmed">24780148</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Y, Speechley KN, Zou G, Campbell C. Factors associated with health-related quality of life in children with duchenne muscular dystrophy. J Child Neurol. 2016;31(7):879&#x2013;86. doi: 10.1177/0883073815627879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0883073815627879</ArticleId><ArticleId IdType="pubmed">26863997</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Y, Speechley KN, Zou G, Campbell C. The relationship between quality of life and health-related quality of life in young males with Duchenne muscular dystrophy. Dev Med Child Neurol. 2017;59(11):1152&#x2013;7. doi: 10.1111/dmcn.13574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dmcn.13574</ArticleId><ArticleId IdType="pubmed">28963725</ArticleId></ArticleIdList></Reference><Reference><Citation>Climans SA, Piechowicz C, Koopman WJ, Venance SL. Survey of Canadian myotonic dystrophy patients&#x2019; access to computer technology. Can J Neurol Sci. 2017;44(5):567&#x2013;71. doi: 10.1017/cjn.2017.47.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cjn.2017.47</ArticleId><ArticleId IdType="pubmed">28535832</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson NE, Ekstrom AB, Campbell C, Hung M, Adams HR, Chen W, et al. Parent-reported multi-national study of the impact of congenital and childhood onset myotonic dystrophy. Dev Med Child Neurol. 2016;58(7):698&#x2013;705. doi: 10.1111/dmcn.12948.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dmcn.12948</ArticleId><ArticleId IdType="pmc">PMC4848162</ArticleId><ArticleId IdType="pubmed">26510705</ArticleId></ArticleIdList></Reference><Reference><Citation>Kullmann J, Pamphlett R. Does the index-to-ring finger length ratio (2D:4D) differ in amyotrophic lateral sclerosis (ALS)? Results from an international online case&#x2013;control study. 2017. doi: 10.1136/bmjopen-2017-016924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-016924</ArticleId><ArticleId IdType="pmc">PMC5726056</ArticleId><ArticleId IdType="pubmed">28784596</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodgkinson VL, Lounsberry J, Mirian A, Genge A, Benstead T, Briemberg H, et al. Provincial differences in the diagnosis and care of amyotrophic lateral sclerosis. Can J Neurol Sci. 2018;45(6):652&#x2013;9. doi: 10.1017/cjn.2018.311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cjn.2018.311</ArticleId><ArticleId IdType="pubmed">30430962</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson-Tarlton CS, Benstead TJ, Doucette S. Correlating factors in the recommendation of feeding tubes in the nutritional management of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(7-8):515&#x2013;21. doi: 10.1080/21678421.2016.1213851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1213851</ArticleId><ArticleId IdType="pubmed">27534658</ArticleId></ArticleIdList></Reference><Reference><Citation>Echigoya Y, Lim KRQ, Melo D, Bao B, Trieu N, Mizobe Y, et al. Exons 45-55 skipping using mutation-tailored cocktails of antisense morpholinos in the DMD gene. Molecular Therapy. 2019;27(11):2005&#x2013;17. doi: 10.1016/j.ymthe.2019.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2019.07.012</ArticleId><ArticleId IdType="pmc">PMC6838919</ArticleId><ArticleId IdType="pubmed">31416775</ArticleId></ArticleIdList></Reference><Reference><Citation>Verhaart IEC, Robertson A, Wilson IJ, Aartsma-Rus A, Cameron S, Jones CC, et al. Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review. Orphanet J Rare Dis. 2017;12(1):124. doi: 10.1186/s13023-017-0671-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-017-0671-8</ArticleId><ArticleId IdType="pmc">PMC5496354</ArticleId><ArticleId IdType="pubmed">28676062</ArticleId></ArticleIdList></Reference><Reference><Citation>Bladen CL, Salgado D, Monges S, Foncuberta ME, Kekou K, Kosma K, et al. The TREAT-NMD DMD global database: Analysis of more than 7,000 duchenne muscular dystrophy mutations. Hum Mutat. 2015;36(4):395&#x2013;402. doi: 10.1002/humu.22758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.22758</ArticleId><ArticleId IdType="pmc">PMC4405042</ArticleId><ArticleId IdType="pubmed">25604253</ArticleId></ArticleIdList></Reference><Reference><Citation>Koeks Z, Bladen CL, Salgado D, van Zwet E, Pogoryelova O, McMacken G, et al. Clinical outcomes in duchenne muscular dystrophy: A study of 5345 patients from the TREAT-NMD DMD global database. J Neuromuscul Dis. 2017;4(4):293&#x2013;306. doi: 10.3233/jnd-170280.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/jnd-170280</ArticleId><ArticleId IdType="pmc">PMC5701764</ArticleId><ArticleId IdType="pubmed">29125504</ArticleId></ArticleIdList></Reference><Reference><Citation>Bladen CL, Thompson R, Jackson JM, Garland C, Wegel C, Ambrosini A, et al. Mapping the differences in care for 5,000 spinal muscular atrophy patients, a survey of 24 national registries in North America, Australasia and Europe. J Neurol. 2014;261(1):152&#x2013;63. doi: 10.1007/s00415-013-7154-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-013-7154-1</ArticleId><ArticleId IdType="pubmed">24162038</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues MJ, O&#x2019;Grady GL, Hammond-Tooke G, Kidd A, Love DO, Baker RK, et al. The New Zealand neuromuscular disease patient registry; five years and a thousand patients. J Neuromuscul Dis. 2017;4(3):183&#x2013;8. doi: 10.3233/jnd-170240.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/jnd-170240</ArticleId><ArticleId IdType="pmc">PMC5611797</ArticleId><ArticleId IdType="pubmed">28800337</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy AJ, Van den Bergh P, Van Damme P, Doggen K, Van Casteren V. Early stages of building a rare disease registry, methods and 2010 data from the Belgian Neuromuscular Disease Registry (BNMDR). Acta Neurol Belg. 2015;115(2):97&#x2013;104. doi: 10.1007/s13760-014-0320-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13760-014-0320-0</ArticleId><ArticleId IdType="pmc">PMC4438257</ArticleId><ArticleId IdType="pubmed">24957677</ArticleId></ArticleIdList></Reference><Reference><Citation>van Engelen BG, van Veenendaal H, van Doorn PA, Faber CG, van der Hoeven JH, Janssen NG, et al. The Dutch neuromuscular database CRAMP (Computer Registry of All Myopathies and Polyneuropathies): Development and preliminary data. Neuromuscul Disord. 2007;17(1):33&#x2013;7. doi: 10.1016/j.nmd.2006.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2006.09.017</ArticleId><ArticleId IdType="pubmed">17141501</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood L, Cordts I, Atalaia A, Marini-Bettolo C, Maddison P, Phillips M, et al. The UK myotonic dystrophy patient registry: Facilitating and accelerating clinical research. J Neurol. 2017;264(5):979&#x2013;88. doi: 10.1007/s00415-017-8483-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-017-8483-2</ArticleId><ArticleId IdType="pmc">PMC5413526</ArticleId><ArticleId IdType="pubmed">28397002</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne BJ, Kishnani PS, Case LE, Merlini L, Muller-Felber W, Prasad S, et al. Pompe disease: Design, methodology, and early findings from the Pompe Registry. Mol Genet Metab. 2011;103(1):1&#x2013;11. doi: 10.1016/j.ymgme.2011.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymgme.2011.02.004</ArticleId><ArticleId IdType="pubmed">21439876</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>